Sept 26 (Reuters) - STALLERGENES GREER PLC STAGR.PA :
* STALLERGENES GREER ADVANCES ITS HOUSE DUST MITE ALLERGY PIPELINE WITH ACCEPTANCE OF REGULATORY SUBMISSION AND NEW MARKET APPROVAL
* HEALTH CANADA ACCEPTED FOR REVIEW NEW DRUG SUBMISSION FOR STG320
* COMPANY ALSO RECEIVED MARKET APPROVAL TO COMMERCIALIZE STG320 IN NEW ZEALAND UNDER ACTAIR BRAND NAME